TGA
- Status: likely_approved
🇦🇺 Abreva in Australia
Abreva (DOCOSANOL) regulatory status in Australia.
Marketing authorisations
TGA
- Status: likely_approved
TGA
- Status: likely_approved
TGA
- Status: likely_approved
TGA
- Status: likely_approved
TGA
- Status: likely_approved
Abreva in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in Australia
Frequently asked questions
Is Abreva approved in Australia?
Yes. TGA has authorised it; TGA has authorised it; TGA has authorised it.
Who is the marketing authorisation holder for Abreva in Australia?
Marketing authorisation holder not available in our data.